AC
GPCR icon

AXQ Capital’s Structure Therapeutics GPCR Stock Holding History

AXQ Capital’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$382K Buy
+7,916
New +$542K 0.05% 509

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

AXQ Capital's GPCR Position: Q1 2026 in Review

AXQ Capital opened a new position in Structure Therapeutics (GPCR) in Q1 2026: 7,916 shares worth $382K. The stake represents 0.05% of the portfolio and ranks #509 among its holdings.

196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • AXQ Capital held 7,916 shares of Structure Therapeutics worth $382K as of Q1 2026.
  • Structure Therapeutics was a new AXQ Capital position in Q1 2026.
  • Structure Therapeutics made up 0.05% of AXQ Capital's portfolio in Q1 2026, its #509 holding.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.